US · Healthcare · Biotechnology
EPS came in at -1.11 against a street estimate of -1.12 — a beat of 0.9%.
Analysts rate Palatin Technologies, Inc. Common Stock a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $53.50.
| Fund | Stake |
|---|---|
| Driehaus Capital Management LLC | 9.36% |
| Jupiter Topco LLC | 7.86% |
| Logos Global Management LP | 7.30% |
| RA Capital Management, LLC | 3.49% |
| Balyasny Asset Management LLC | 2.31% |
| Morgan Stanley - Brokerage Accounts | 1.53% |
| Opaleye Management Inc | 1.15% |
| Geode Capital Management, LLC | 1.09% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Palatin Technologies, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.